Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
about
Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoidOmalizumab, an anti-immunoglobulin E antibody: state of the art.Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.Pemphigoid diseases: pathogenesis, diagnosis, and treatment.Immunoglobulin E-binding autoantigens: biochemical characterization and clinical relevance.Anti-IgE--emerging opportunities for Omalizumab.BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.Off-Label Uses of Omalizumab.IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature.Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses.A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease.Evidence for a role of eosinophils in blister formation in bullous pemphigoid.Biomarkers related to bullous pemphigoid activity and outcome.IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.Eosinophils as putative therapeutic targets in bullous pemphigoid.Immunoglobulin E-Mediated Autoimmunity.Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
P2860
Q27346806-48F3BE6F-7E8E-4CF6-A29E-709CB72902F7Q35095218-FFB08DE7-F9F8-44D7-BA02-D110A66B046FQ35888702-3B14C081-7F98-4549-B18B-72F712978439Q36453830-C9F1F19A-8D29-4137-BDFB-A160F8E1F7DBQ37933427-A3C90135-BD6E-44F7-97C2-2D22AEC02C23Q37957215-58163074-4A23-4E6C-ACFD-85ECE440696DQ38091754-6D830D52-341A-4DC3-BCCA-DBA5B13F5882Q38193888-F1AF0E26-B931-408B-96A8-F83CE2F15276Q38213200-9F21709A-AA42-484F-BDE6-DCC1BC2018C2Q38517653-F3721291-A968-4C91-B176-4EB36EB9FAC1Q38640323-EA950FD0-DACF-40EB-95F0-404141FA4497Q38752194-B205642B-27F5-4CED-9D3D-20288F3E4384Q38881180-A7A5EB02-F386-4D0B-A6D3-1C7FDD7CB087Q39122684-37725510-1BA0-4B98-B5EE-D932C1036DB4Q43103854-C7728C20-5D00-431B-836F-EFD44C315DB3Q44014033-BCF80630-6A96-4050-91BF-C5E76406695CQ46425853-4768C9D2-82FE-42BD-88F5-E389834BBCF4Q47438953-C7AD449F-4502-4FB5-8809-A50BD27B76F5Q47602330-56E5CB4E-38AC-498C-B542-ADE9C584EFE8Q47916162-76EBC464-C6EF-4FAD-A59B-C7E7BB150B67Q52804420-237FCB2A-9B2B-4E3D-A591-D1BBAE9CFD8AQ52845120-6EFA9FD3-E794-4824-853D-512953A12D14Q52996461-651FAB43-91C3-4906-8750-AE36335964A3Q55104920-7875BBE5-A1E4-43E4-B1E2-DF8FB3265439
P2860
Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@ast
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@en
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@nl
type
label
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@ast
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@en
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@nl
prefLabel
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@ast
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@en
Pathogenicity of IgE in autoim ...... us pemphigoid with omalizumab.
@nl
P2093
P2860
P1476
Pathogenicity of IgE in autoim ...... ous pemphigoid with omalizumab
@en
P2093
Christian L Baum
Debra S Brandt
Kelly A N Messingham
P2860
P304
P356
10.1016/J.JACI.2008.11.035
P407
P577
2009-01-18T00:00:00Z